• OPEN AN ACCOUNT
Indian Indices
Sensex
76,798.84 -465.67
( -0.60%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Colgate-Palmolive (India) Ltd
Industry :  Personal Care - Multinational
BSE Code
ISIN Demat
Book Value()
500830
INE259A01022
58.2423616
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COLPAL
36.37
49792.41
EPS(TTM)
Face Value()
Div & Yield %
50.33
1
3.17
 

yaari digital integrated services ltd
Emcure receives EIR report for its formulations facility at Sanand, Gujarat
Aug 08,2026
Emcure Pharmaceuticals announced that the Company has received the Establishment Inspection Report (EIR) from the USFDA for its formulations facility located at G.I.D.C., Taluka - Sanand, Ahmedabad. The USFDA has classified the inspection status of the said facility as Voluntary Action Indicated (VAI) and accordingly, the inspection stands closed.